Schedule 1

Article 3 of the Articles of Incorporation of Anavex Life Sciences Corp. is hereby amended to add the following paragraph: "In addition to the authorized shares of common stock, the corporation is authorized to issue 10,000,000 shares of preferred stock. The preferred stock may be issued from time to time in one or more series. The board of directors is authorized to fix the number of shares and the par value per share of any series of preferred stock and to determine the designation of any such series.

The board of directors is also authorized to determine or alter the rights, preferences, privileges, and restrictions granted to or imposed upon any wholly unissued series of preferred stock (which rights, preferences and privileges may be prior to the common stock or any previously issued series of preferred stock) and, within the limits and restrictions stated in any resolution or resolutions of the board of directors originally fixing the number of shares constituting any series, to increase or decrease (but not below the number of shares of such series then outstanding) the number of shares of any such series subsequent to the issue of shares of that series.”